Anlotinib Shows Efficacy in ASPS Patients in Phase II Study in China
A presentation is the recent annual meeting of the American Society of Clinical Oncology (ASCO) conference in Chicago highlighted the new drug Anlotinib and its efficacy in treating Alveolar Soft Part Sarcoma patients. Anlotinib is a new receptor tyrosine kinase inhibitor, currently in phase II clinical trials in China. Patients with different types of soft […]
New ASPS Clinical Trial: Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas
New clinical trial for ASPS is expected to open on March 2016. Study number: NCT02636725 This is a phase II clinical trial that combines treatment with Axitinib and Pembrolizumab in patients with advanced Alveolar Soft Part Sarcoma (ASPS) and other soft tissue sarcomas. Axitinib (AG013736; trade name Inlyta) is a small molecule tyrosine kinase inhibitor. […]
Donation for ASPS Research in Honor of Kevin Kanai Griffith
iCureASPS thanks Liz Cooper, “Gamers For Good†and all the wonderful donors for the very generous donation of $15,000 aimed towards finding a cure for Alveolar Soft Part Sarcoma (ASPS). This donation helps to extend the collaboration of iCureASPS with the Dana Farber Cancer Institute in Boston, which has been ongoing since 2004. Liz Cooper, […]
Alveolar Soft Part Sarcoma Tumor Metabolizes Lactate by Goodwin and Jin et al in “Cancer Cell†Journal
Cancer Cell 26, 851-862, December 8,2014 The research from the group of Dr. Kevin Jones from the university of Utah was published in December 2014. It gives very important information on the metabolism of ASPS. It demonstrates that lactate drives proliferation of ASPS. The full paper is available here. The researchers initiated the study by creating […]
This Weekend Team ASPS Participated for the 12th Time in the PMC Bike Ride and Continues to Raise Funds to Sponsor Research on ASPS at the Dana Farber Cancer Institute in Boston
Dear ASPS community, this weekend (August 1-2) Team ASPS participated for the 12th time in the Pan-Massachusetts Challenge (PMC).This is a bikea thon that crosses Massachusetts to raise money for cancer research and clinical trials at the Dana-Farber Cancer Institute in Boston. Donations for Team ASPS are restricted for research on ASPS only. I would […]
Important Announcement: CASPS – A Phase II Trial of Cediranib in the Treatment of Patients with Alveolar Soft Part Sarcoma
OPEN NOW: CASPS – A Phase II Trial of Cediranib in the Treatment of Patients with Alveolar Soft Part Sarcoma Sponsored by: The Institute of Cancer Research / The Royal Marsden NHS Foundation Trust Information provided by: The Institute of Cancer Research – Clinical Trials and Statistics Unit ClinicalTrials.gov Identifier: NCT01337401 Cediranib (AZD2171) is a […]
Thank You Somerset Middle School!
Dear iCureASP Community, I would like to thank the special students and teachers at Somerset Middle School in Wisconsin for their act of kindness and generosity. They made a decision to support the search for the much needed cure for Alveolar Soft Part Sarcoma. Recently in my mailbox I found a donation with the following kind […]
Donate now and support the development of cure for ASPS
We are opening iCureASPS annual fundraiser with the traditional PMC bike ride. Our ASPS team rides yesterday and today for the 10th year at the Pan-Massachusetts Challenge (PMC). Ten years have passed since we founded our group and started to look for a cure for Alveolar Soft Part Sarcoma (ASPS), a rare cancer that has […]
A Summary of Phase II Cederanib Clinical Trial
The summary of the phase 2 clinical trial of Cediranib on Alveolar Soft Part Sarcoma was recently published in the “Journal of Clinical Oncology” by Shivaani Kummar and others from the National Cancer Institute and the Frederick National Laboratory for Cancer Research. The authors report that Cediranib has substantial single-agent activity, producing an objective response […]
The 9th PMC bike ride of “Team ASPS”: More donations for preclinical studies of Alveolar Soft Part Sarcoma
On the first weekend of August 2012, “Team ASPS†participated for the 9th time in the Pan-Massachusetts Challenge (PMC) bike ride. This bike-a-thon crosses Massachusetts to raise money for cancer research and treatment at the Dana-Farber Cancer Institute (DFCI) in Boston. Our team rode 90 miles and raised $30,705 specifically dedicated for finding a cure […]